MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway.
Saved in:
| Title: | MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway. |
|---|---|
| Authors: | Guan, Rui1,2 (AUTHOR), Li, Ce1,2 (AUTHOR), Jiao, Ruijie1,2 (AUTHOR), Li, Jingao1,2 (AUTHOR), Wei, Ran1,2 (AUTHOR), Feng, Chen1,2 (AUTHOR), Cao, Shengda1,2 (AUTHOR), Qian, Ye1,2 (AUTHOR), Fang, Jugao3,4 (AUTHOR), Liu, Jun5 (AUTHOR), Li, Wenming1,2 (AUTHOR), Wei, Dongmin1,2 (AUTHOR), Lei, Dapeng1,2 (AUTHOR) leidapeng@sdu.edu.cn |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 7/26/2025, Vol. 44 Issue 1, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17569966 |
|---|---|
| DOI: | 10.1186/s13046-025-03482-9 |
